Opinions Split On Newly Approved Myeloma Therapies At ASH

Doctors debated which new therapies they would prefer to use for the treatment of multiple myeloma and when they thought emerging treatments should become an option for their patients, during the first day of the Annual Meeting for the American Society of Hematology (ASH).

Doctors debated which new therapies they would prefer to use for the treatment of multiple myeloma and when they thought emerging treatments should become an option for their patients, during the first day of the Annual Meeting for the American Society of Hematology (ASH).

In a Satellite Symposium titled "Global Advances in Myeloma: Providing Best Options for Treatments in 2015," program director Dr. Brian...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category